(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Atorvastatin recall may affect hundreds of thousands of patients – and reflects FDA’s troubles inspecting medicines manufactured overseas - 2Poland open to German troops to help secure Ukraine ceasefire
- 3Vote in favor of your Number one Kind of Gems
- 4Trump says Venezuela will start 'turning over' oil to the U.S. Is that the reason he toppled Maduro — or is it something else?
- 5Find the Historical backdrop of Common liberties: Advancing Equity and Equity Around the world
- Top 20 Style Brands for Pioneers
- 'Zootopia 2' movie reviews: A heartwarming, hysterical and earnest 'ode to community'
- Spanish police and soldiers track boars, reinforce farm security amid swine fever outbreak
- 5 Cell phones of the Year
- Israel approves 19 new West Bank settlements in major annexation push
- Jury says Johnson & Johnson owes $40 million to 2 cancer patients who used talcum powders
- What we know about Renee Nicole Good, the woman who was killed by an ICE officer in Minneapolis
- Astronomers detect black hole blasting winds at incredible speeds
- Chicago reports first rabies-positive dog in 61 years. What we know.
